Is Minerva Surgical, Inc. technically bullish or bearish?
2025-09-20 19:36:05As of 13 June 2025, the technical trend for Minerva Surgical, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators. The MACD is mildly bullish on both weekly and monthly time frames, while the RSI shows a bullish monthly reading but none on the weekly. Moving averages indicate a mildly bearish daily trend. Additionally, the KST is bearish on the weekly and neutral on the monthly, and Dow Theory shows no trend in both time frames. In terms of performance, the company has significantly underperformed the S&P 500 over the past year, with a return of -99.17% compared to the S&P 500's 17.14%....
Read MoreIs Minerva Surgical, Inc. overvalued or undervalued?
2025-09-20 18:11:21As of 11 May 2022, the valuation grade for Minerva Surgical, Inc. has moved from does not qualify to risky, indicating a significant deterioration in its financial standing. The company appears to be overvalued given its current metrics, particularly with a P/E ratio of 0.00, an EV to EBIT of -0.85, and an EV to EBITDA of -1.14, which suggest a lack of profitability and operational efficiency. In comparison to its peers, Silk Road Medical, Inc. has a P/E ratio of -19.76 and an EV to EBITDA of -18.12, while Cytek Biosciences, Inc. shows a P/E of -33.33 and an EV to EBITDA of -15.41, both indicating that Minerva Surgical is underperforming relative to its industry. Additionally, the company's one-year return of -99.17% starkly contrasts with the S&P 500's return of 17.14%, reinforcing the notion that Minerva Surgical is struggling significantly in the market....
Read More





